Manufacturing is having its moment in #CGT. The challenge isn’t just scaling production, it’s maintaining genomic continuity. FormManufacturing helps teams optimize constructs upstream and quantify lot-to-lot comparability downstream.
Learn More: na2.hubs.ly/H05MQ0Y0
In the 2nd episode of The Algorithm of Life, our CEO Michelle Chen sits down with Dr. Lee Hood, the pioneer of #systemsbiology. "I've always had a lot of faith in the power of big questions to point you in the right direction..." — Dr. Hood 🎙️hubs.li/Q04hx6vC0#genomics
We’ll be at @Biocom’s #ConvergeSummit April 23, where Michelle Chen, Ph.D., CEO of Form Bio, will be speaking during the lightning talks from 1:30–1:55 PM. Looking forward to connecting!
We’re heading to the 3rd International Human Gene Therapy Conference in Boston (March 23–25). Catch Jeremy Shelley on March 23 at 11:30am: “Optimizing #GeneTherapy Development Through Long-Read Sequencing.” If you’re attending, let’s connect: hubs.li/Q047zht50
In our inaugural #podcast, Michelle Chen, CEO of Form Bio, sits down with Rich Horgan, Founder & CEO of the @CureRareDisease, to share a deeply personal story that became a mission, accelerating #CellandGeneTherapy development for rare diseases. hubs.li/Q045CxPg0
Exciting publication alert! AlphaGenome, published in Nature by Google DeepMind, represents a major milestone in genomic #AI, building on nearly a decade of incremental progress toward unified, sequence-to-function modeling of regulatory biology. hubs.li/Q045q8dG0
Form Bio is headed to Nashville (Feb 19–20) for Frontiers 2026, Phase Capital’s annual summit, where our CEO will join the panel “Beyond the Hype Cycle: Practical Applications of #AI.” We'll explore where AI is delivering real biological insight today.
hubs.li/Q040y7hk0
Proud to announce our partnership with Cure Rare Disease! 🌟
Already: 4.4x boost in AAV yield for a #DMD candidate. Together, we’re accelerating safer, more effective therapies for rare & ultra-rare diseases.
accessnewswire.com/newsroom/…#GeneTherapy#RareDisease
🌵🧬 We're headed to @alliancerm#CGMesa25, Oct 6-8! We'd love to connect and share our latest aggregate biological data validating our #AI/ML models : hubs.li/Q03L2Swm0
🚀 We’re thrilled to welcome Michelle Chen, Ph.D. as Form Bio’s new President & CEO!
With 25 years in AI-driven drug discovery, biotech & pharma—including at @InSilicoMeds—she brings the vision to scale our #AI expertise in #geneticmedicine
👉 hubs.li/Q03D6TXf0
🎉 Big congrats to Brandi Cantarel, PhD, VP of Bioinformatics at @FormBio, for being named one of @DallasInnovates’ Top 75 #AI Innovators in North Texas! 👏
She’s pioneering AI in #genomics to accelerate breakthroughs in human health.
🧬 Read more: hubs.li/Q03ltj0y0
We’re heading to #ASGCT25! Pre-book a meeting with our team or stop by booth #1143 to learn how to improve #AAV#genetherapy development.
Join us for in-booth activities featuring our partners Azenta, PacBio and Stanford University.
hubs.li/Q03lkL8h0
Form Bio is the tech turning visionary science into reality.
From de-extinction to cutting-edge #CGT, our tools design #CRISPR guides at scale, detect off-target edits, & predict functional impact.
Let’s talk how we can support your next breakthrough.
hubs.li/Q03khCRt0
The woolly mouse is what happens when visionary science meets cutting-edge #AI.
At Form Bio, we’re not just powering de-extinction—we’re building tech that’s transforming #geneediting for human health.
Learn more. hubs.li/Q03jCLD20
Form Bio is proud to be the tech behind Colossal’s dire wolf project, advancing large-scale comparative #genomics to analyze ancient DNA alongside genomes of related species to unlock key phenotypic traits. Learn more:
hubs.ly/Q03hjsgF0
🌟Newly Announced Speakers for the #AAV Innovation Summit–Mar 20 @NCBiotech. Early bird registration ends Feb 28—register now & save $100! Networking reception to follow.
🔗hubs.li/Q038rrQv0#genetherapy